Ampio Pharmaceuticals Inc
AMPE
Get informed when a big investor buys or sells
+ FollowMarket Cap$207.88K
Close$
$1.68
815% upside
Current Fair Value
815% upsideUndervalued by 815% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $207,884.00 |
|---|---|
| Enterprise Value | $-3,607,116.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-10.67 |
| Beta | 6.07 |
| Outstanding Shares | 826,000 |
Return
| Return on Equity | -247.89% |
|---|---|
| Return on Assets | -145.21% |
| Return on Invested Capital | -270.71% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.71 |
| Price to Sales | - |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.4 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
$-6.00
Average shareholder expectationRevenue Estimate
$245,000
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-6.00
Average shareholder expectationRevenue Estimate
$245,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 0.00% |
|---|---|
| Total Invested | $67▲ 3250.00% |
| Investors Holding | 10% |
ESG Score
No data
About Ampio Pharmaceuticals Inc
CEO: Michael Macaluso